Pitot H C
Am J Pathol. 1977 Nov;89(2):402-11.
The stages of initiation and promotion in the natural history of epidermal carcinogenesis have been known for many years. Recently, experimental systems other than skin have been shown to exhibit similar, if not completely analogous, stages in the natural history of neoplasia. In particular, the demonstration by Peraino and his associates that phenobarbital may enhance the production of hepatomas by a relatively subcarcinogenic dose of acetylaminofluorene was one of the first demonstrations of stages occurring in an extraepidermal neoplasm. Studies reported in this paper have demonstrated that administration of phenobarbital (0.05% in the diet) for 6 months following a single dose of diethylnitrosamine (5 to 10 mg/kg) given within 24 hours after partial hepatectomy resulted in a marked increase in the number of enzyme-altered foci in the liver as well as in the production of hepatocellular carcinomas. This was compared to animals receiving only a single dose of diethylnitrosamine following partial hepatectomy with no further treatment, in which only a relatively small number of foci were evident in the absence of phenobarbital feeding. Using three different enzyme markers, a distinct degree of phenotypic heterogeneity of the enzyme-altered foci in liver was demonstrated. These studies have shown that liver carcinogensis can be readily divided into two stages: a) initiation by a single dose of diethylnitrosamine following partial hepatectomy and b) promotion by the continuous feeding of phenobarbital. Furthermore, the immediate progeny of the initiated cells, the enzyme-altered focus, may be recognized by suitable microscopic means prior to the formation of gross lesions as required in the skin system. These initiated cell populations exhibit a degree of biochemical heterogeneity which reflects that seen in fully developed hepatic neoplasms, suggesting that promotion and progression in this system does not significantly alter the basic biochemical characteristics of the initiated cell.
表皮癌发生自然史中的启动和促进阶段已为人所知多年。最近,已证明除皮肤外的其他实验系统在肿瘤形成的自然史中表现出相似(即便不是完全类似)的阶段。特别是,佩拉伊诺及其同事证明,苯巴比妥可能会增强相对低于致癌剂量的乙酰氨基芴诱发肝癌的作用,这是表皮外肿瘤发生阶段的首批证明之一。本文报道的研究表明,在部分肝切除术后24小时内给予单剂量二乙基亚硝胺(5至10毫克/千克)后,连续6个月在饮食中添加0.05%的苯巴比妥,会导致肝脏中酶改变灶的数量以及肝细胞癌的产生显著增加。与之相比,仅在部分肝切除术后接受单剂量二乙基亚硝胺且未进一步治疗的动物,在不喂食苯巴比妥的情况下,仅出现相对较少的病灶。使用三种不同的酶标记物,证明了肝脏中酶改变灶存在明显程度的表型异质性。这些研究表明,肝癌发生可轻易分为两个阶段:a)部分肝切除术后单剂量二乙基亚硝胺引发;b)持续喂食苯巴比妥促进。此外,引发细胞的直接后代,即酶改变灶,在肉眼可见病变形成之前,可通过合适的显微镜方法识别,这与皮肤系统的要求相同。这些引发细胞群体表现出一定程度的生化异质性,这与完全发育的肝脏肿瘤中的情况相似,表明该系统中的促进和进展不会显著改变引发细胞的基本生化特征。